title: Testing for human papillomavirus in BRAF inhibitor-associated verrucous keratoses.
authors.affiliation: School of Pathology and Laboratory Medicine, The University of Western Australia, Perth, Australia.
authors.forename: Britt
authors.initials: B
authors.lastname: Clynick
authors.forename: Tania
authors.initials: T
authors.lastname: Tabone
authors.forename: Kathy
authors.initials: K
authors.lastname: Heel
authors.forename: Wendy
authors.initials: W
authors.lastname: Erber
authors.forename: Benjamin A
authors.initials: BA
authors.lastname: Wood
authors.forename: Michael
authors.initials: M
authors.lastname: Millward
authors.forename: Nathan T
authors.initials: NT
authors.lastname: Harvey
mesh_terms: D006801:Humans; D007642:Keratosis / Q000139:chemically induced / Q000473:pathology / Q000821:virology*; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000821:virology; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D047428:Protein Kinase Inhibitors; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf
keywords: B-Raf inhibitors; human papillomavirus; verrucous keratoses